【2027】Call for Proposals: Kaohsiung Medical University–National Health Research Institutes Joint Research Projects

Purpose

Kaohsiung Medical University (hereinafter referred to as “KMU”) and the National Health Research Institutes (hereinafter referred to as “NHRI”) invite applications for integrated research projects aimed at establishing interdisciplinary collaboration in translational medicine and promoting the development of the biotechnology industry.

Eligibility

  1. Each project must have one Program Principal Investigator (Program PI) from KMU and one from NHRI.

  2. Each subproject must be led by either a full-time KMU faculty/staff member or an eligible NHRI member serving as the Subproject Principal Investigator (Subproject PI).

  3. All Subproject PIs must meet the eligibility requirements for applying for research grants from the National Science and Technology Council (NSTC).

  4. Each Program PI must also serve as the PI of one subproject.

  5. Each applicant may submit only one proposal.

Applicants who have previously received funding under this program but failed to meet the designated KPIs for the applicable year are not eligible to apply.

Note 1: KMU PIs should take their existing workload into consideration. In principle, each applicant may concurrently conduct no more than two intramural or inter-university research projects coordinated by the Office of Research and Development.

Note 2: NHRI PIs must be full-time PIs, project PIs, attending physicians, or jointly appointed PIs with resources equivalent to those of full-time PIs. Researchers seconded to other institutions are not eligible.

For information regarding application limits and disclosure requirements for NHRI PIs applying for 2027 joint research projects, please refer to the NHRI announcement:
https://pd.nhri.edu.tw/nhri-joint-grants-list-fy116/

Schedule

  • Application deadline: From the date of announcement to 12:00 noon, October 12, 2026. Late applications will not be accepted.

  • Announcement of selection results: By December 31, 2026.

  • Project period: January 1, 2027 to December 31, 2027.

Application Guidelines

  1. Research fields: No restrictions.

  2. Project type: All proposals must be integrated research projects. Each project must consist of at least three subprojects, with a maximum of five subprojects.

KPIs for 2027 Projects

The PIs of funded teams must apply for an external integrated research project within two years of project approval. The PIs of such external projects must include full-time teaching or research personnel from both institutions.

In addition, applicants must meet at least one of the following requirements to be eligible to apply for a new research project:

  1. Within two years of project approval, at least one journal article arising from a funded subproject must be published with the Subproject PI as the first or corresponding author and must be co-authored by full-time teaching or research personnel from both institutions.

  2. Within two years of project approval, the team must obtain at least one externally funded integrated research project whose PIs include full-time teaching or research personnel from both institutions.

  3. Within two years of project approval, the team must, with institutional approval, file at least one patent for which PIs from both institutions are named as inventors and both institutions jointly own the patent rights; or complete at least one technology transfer with licensing revenue equal to or greater than the amount of funding provided under this project.

  4. Within two years of project approval, the team must obtain at least one government-funded industry–academia collaboration project with funding equal to or greater than the amount awarded under this project. The PIs must include full-time teaching or research personnel from both institutions.

Research outcomes funded by this program may not be published in journals considered controversial. Please refer to the following link for the list of such journals:
https://rd.mc.ntu.edu.tw/bomrd/ntu2/file.asp?filename=2022422114920.pdf

  1. Publications resulting from this project must include the following funding acknowledgment:

Chinese: 「XX年高雄醫學大學與國家衛生研究院合作研究計畫(#NHRI-KMU-116-計畫編號)」
English: “NHRI-KMU Joint Research Project (#NHRI-KMU-116-[Project Number]).”

Research Ethics and Required Approvals

Projects involving human subjects research, clinical trials, human embryos or embryonic stem cell research, recombinant DNA experiments, field trials involving genetically modified organisms, experiments involving Risk Group 2 or higher infectious biological materials, or animal experiments must provide approval documents issued by the relevant review or regulatory bodies.

Applicants must submit proof of application for the required approval within one month after receiving notification of funding and submit the official approval documents within four months. The research title and project period stated in the approval documents must be consistent with those of the approved project.

Funding will not be disbursed until all required approval documents have been submitted. Failure to provide the required documents within the specified period will be deemed a waiver of the project.

Final Report: The applicant’s institution will notify the project team to submit a final report within three months after completion of the project.

Funding and Eligible Expenses

  1. The maximum approved funding for each project is NT$3.5 million per year.

  2. KMU and NHRI will each disburse funding to their respective project personnel. The management of revenues and expenditures, accounting procedures, laboratory safety, research ethics, and related matters shall be handled in accordance with the regulations and procedures of the respective funding institution.

  3. Eligible expenses include materials, operating expenses, personnel expenses, maintenance expenses, domestic travel expenses, and equipment expenses required for conducting the research. These expense categories are subject to annual adjustments in accordance with the regulations of the respective funding institution and may not be transferred to or used interchangeably with other funds within the institution.

  4. Ten percent (10%) of the total funding provided by KMU must be allocated to either:
    a. capital expenditures; or
    b. operating expenses for the use of instruments and commissioned services within the KMU healthcare and education system.

    NHRI funding for the current year does not include capital expenditures.

Ownership of Research and Development Outcomes

Unless otherwise stipulated, ownership of technologies, trade secrets, and other intellectual property rights arising from the collaboration shall be governed by the academic collaboration agreement signed by KMU and NHRI.

Compliance with Academic Ethics

Any personnel participating in a joint research project who violate academic ethics during the conception, implementation, or presentation of research outcomes shall be handled in accordance with the regulations and review procedures for academic ethics cases of their respective institutions.

Important Reminder Regarding Project Fund Management

PIs who are currently conducting intramural or extramural research projects must pay close attention to the deadlines for the use of project funds. If budget modifications, procurement of instruments or equipment, or other administrative procedures are required, PIs should consult the relevant administrative offices well in advance and properly plan the timeline for each stage of the process.

Priority Research Areas and Additional Funding

To leverage KMU’s key areas of expertise and strengthen representative interdisciplinary research, teams are encouraged to develop in-depth proposals focusing on specific research topics.

Proposals that clearly align with the following key development areas and R&D objectives and successfully pass the review process may be given priority consideration and may receive additional research funding as appropriate:

  1. Establishment of a biobank related to environmental pollution, including medical records, lifestyle questionnaires, genome sequencing, transcriptome sequencing, and pollutant measurements for at least 30 cases.

  2. Establishment of a GMP- or GMP-like-grade platform for new drug production.

  3. Indigenous health and cultural revitalization.

Application Procedure

The Program PIs from both institutions must submit both PDF and MS Word versions of the following documents by email to the designated contact person at their respective institutions no later than 12:00 noon on October 12, 2026:

  1. Research Proposal: Including the CVs of the Program PIs and Subproject PIs. Both institutions must submit the same version of the proposal. Please use the provided template.

  2. Checklist and Declaration Form: Applicants must verify their compliance with all applicable requirements. The form must be signed by the Program PIs and all Subproject PIs.

  3. KMU Program PIs must log in to the KMU Administrative Information System and access T.3.0.27 “Applied Project Registration” to register the application and upload the research proposal, including the self-checklist. Please enter “116” as the application year.

  4. KMU applicants are expected to assist the Office of Research and Development by serving as reviewers for KMU intramural and inter-university research projects. Reviewer honoraria will be provided by the Office of Research and Development. Applicants are encouraged to assist with the review process. If there is any conflict of interest involving the applicant or the submitted proposal, please disclose it and recuse yourself from the review.

Contact Information

Kaohsiung Medical University (KMU)
Mr. Shuai-Lun Lu
Tel: +886-7-312-1101 ext. 2341
Email: shuailun@kmu.edu.tw

National Health Research Institutes (NHRI)
Ms. Chia-Yu Ting
Tel: +886-37-206-166 ext. 33006
Email: elsa@nhri.edu.tw

Go to top